FDA.reportPublic FDA data

triamcinolone acetonide 0.147 MG/ML Topical Spray

RxCUI
1085736
RxNorm name
triamcinolone acetonide 0.147 MG/ML Topical Spray
Display name
Triamcinolone (Topical)
Full name
triamcinolone acetonide 0.147 MG/ML Topical Spray
Term type
SCD
Status
Active
Strength
0.0147%
Dose form
Spray
Route
Topical
Updated
2026-06-14 07:04:47

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triamcinolone acetonide0.147 MG / 1 MLtriamcinolonetriamcinolone acetonide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Spray346165

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triamcinolone10759

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRtriamcinolone acetonide 0.147 MG/ML Topical SprayNAMES
RxNorm Nametriamcinolone acetonide 0.147 MG/ML Topical SprayNAMES
RxNorm Synonymtriamcinolone acetonide 0.147 MG/GM Topical SprayNAMES
TTYSCDATTRIBUTES
SPL_SET_ID8c8307ed-d0c9-4f74-84a8-1471677a4f2aCODES
RxCUI1085736CODES
MMSL_CODEBD3373CODES
MMSL_CODECD3373CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
45802-045-0145802-045Triamcinolone Acetonide Triamcinolone AcetonidePadagis Israel Pharmaceuticals LtdANDA205782
45802-045-0245802-045Triamcinolone Acetonide Triamcinolone AcetonidePadagis Israel Pharmaceuticals LtdANDA205782

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA20578245802-045Triamcinolone Acetonide Triamcinolone AcetonideANDAPadagis Israel Pharmaceuticals Ltd

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
45802004501rxnav_ndcsyes
45802004502rxnav_ndcsyes
61748021810rxnav_ndcsyes
61748021863rxnav_ndcsyes
63629240601rxnav_ndcsyes
63629240701rxnav_ndcsyes
64980042901rxnav_ndcsyes
64980042963rxnav_ndcsyes
72162180601rxnav_ndcsyes
72162180602rxnav_ndcsyes
00003050162rxnav_historical_indirect
51125041206rxnav_historical
51125041210rxnav_historical
54569215300rxnav_historical_indirect
54868325500rxnav_historical_indirect
71800015631rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8c8307ed-d0c9-4f74-84a8-1471677a4f2atriamcinolone acetonide 0.147 MG/GM Topical SpraySY6Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g20230501
8c8307ed-d0c9-4f74-84a8-1471677a4f2atriamcinolone acetonide 0.147 MG/ML Topical SpraySCD6Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g20230501
8c8307ed-d0c9-4f74-84a8-1471677a4f2atriamcinolone acetonide 0.147 MG/GM Topical SprayPSN6Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g20230501

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
8c8307ed-d0c9-4f74-84a8-1471677a4f2aTriamcinolone Acetonide Topical Aerosol USP, 0.147 mg/gPadagis Israel Pharmaceuticals Ltd20230501

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4triamcinolone
ATCR01ADCorticosteroidsATC1-4triamcinolone
ATCA01ACCorticosteroids for local oral treatmentATC1-4triamcinolone
ATCD07ABCorticosteroids, moderately potent (group II)ATC1-4triamcinolone
ATCD07XBCorticosteroids, moderately potent, other combinationsATC1-4triamcinolone
ATCS01BACorticosteroids, plainATC1-4triamcinolone
ATCR03BAGlucocorticoidsATC1-4triamcinolone
ATCH02ABGlucocorticoidsATC1-4triamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone
MEDRTD014221TriamcinoloneCHEMhas_ingredienttriamcinolone
MEDRTD014222Triamcinolone AcetonideCHEMhas_ingredienttriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone acetonide
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone acetonide
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone acetonide
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone acetonide
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone acetonide
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone acetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone acetonide
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone
MEDRTD007239InfectionsDISEASEci_withtriamcinolone acetonide
MEDRTD007239InfectionsDISEASEci_withtriamcinolone
MEDRTD007249InflammationDISEASEmay_treattriamcinolone acetonide
MEDRTD007249InflammationDISEASEmay_treattriamcinolone
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone acetonide
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone acetonide
MEDRTD009181MycosesDISEASEci_withtriamcinolone
MEDRTD009181MycosesDISEASEci_withtriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone acetonide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.147 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESANDAANDA205782
CODESMMSL_CODEBD3373
CODESMMSL_CODECD3373
CODESRxCUI1085736
CODESSPL_SET_ID8c8307ed-d0c9-4f74-84a8-1471677a4f2a
CODESVUID4015849
CODESVUID4035887
NAMESPrescribable Synonymtriamcinolone acetonide 0.147 MG/GM Topical Spray
NAMESRXNAV_STRtriamcinolone acetonide 0.147 MG/ML Topical Spray
NAMESRxNorm Nametriamcinolone acetonide 0.147 MG/ML Topical Spray
NAMESRxNorm Synonymtriamcinolone acetonide 0.147 MG/GM Topical Spray
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File